A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors
Clinical and Translational Oncology · 2025
DOI: 10.1007/s12094-025-04142-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von Juan Carlos Redondo-González und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, University Hospital of Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Sex Characteristics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Immunotherapy has led to a paradigm shift in the treatment of various tumors. However, the results obtained sometimes show heterogeneous and inconsistent responses despite the presence of biomarkers such as PD-L1. Recent studies suggest that the efficacy of immunotherapy may vary based on sex, although the findings remain controversial. The aim of this comprehensive review is to evaluate the available evidence and the biological mechanisms that could explain these differences. Some recent meta-analyses have suggested a greater overall survival benefit for males. Theoretical models, supported by in vivo studies in different animal species, are currently focused on the implications of the tumor microenvironment, hormonal factors in the antitumor activity of the immune system and their correlation with the patient's sex. Other chromosomal sex-specific alterations could be influenced by epigenetic changes affecting genetic material. Prospective studies are needed to further investigate the uncertain relationship between sex and immunotherapy in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Oncology Department, University Hospital of Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain.
- Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain.
- Faculty of Medicine, University of Salamanca, Salamanca, Spain.
- Radiation Oncology Department, University Hospital of Salamanca, Salamanca, Spain.
- Medical Oncology Department, University Hospital of Salamanca, Paseo de San Vicente, 182, 37007, Salamanca, Spain. aolivares@saludcastillayleon.es.
- Biomedical Research Institute of Salamanca (IBSAL), Salamanca, Spain. aolivares@saludcastillayleon.es.
Zitieren
APA
Redondo-González, J. C., Posado-Domínguez, L., Corvo-Félix, L., Bellido Hernández, L., Miguel-Arregui, I. S., Fonseca-Sánchez, E., Olivares-Hernández, A., & Del Barco-Morillo, E. (2025). A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04142-2
Vancouver
Redondo-González JC, Posado-Domínguez L, Corvo-Félix L, Bellido Hernández L, Miguel-Arregui IS, Fonseca-Sánchez E, et al. A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04142-2
BibTeX
@article{RedondoGonzlez2025,
author = {Redondo-González, Juan Carlos and Posado-Domínguez, Luis and Corvo-Félix, Laura and Bellido Hernández, Lorena and Miguel-Arregui, Iñigo San and Fonseca-Sánchez, Emilio and Olivares-Hernández, Alejandro and Del Barco-Morillo, Edel},
title = {A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors},
journal = {Clinical and Translational Oncology},
year = {2025},
doi = {10.1007/s12094-025-04142-2}
}
EUVIMED